During the past decade, Hôpital Arnaud de Villeneuve; Néphrologie pédiatrique conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Arnaud de Villeneuve; Néphrologie pédiatrique" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Arnaud de Villeneuve; Néphrologie pédiatrique" are "Atypical Hemolytic Uremic Syndrome" (2 trials). Many other conditions were trialed in "Hôpital Arnaud de Villeneuve; Néphrologie pédiatrique" in a lesser frequency.

Most popular intervention types in "Hôpital Arnaud de Villeneuve; Néphrologie pédiatrique" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Crovalimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Arnaud de Villeneuve; Néphrologie pédiatrique" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Arnaud de Villeneuve; Néphrologie pédiatrique". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hôpital Arnaud de Villeneuve; Néphrologie pédiatrique, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Arnaud de Villeneuve; Néphrologie pédiatrique, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".